257 related articles for article (PubMed ID: 19800577)
1. Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model.
Bric A; Miething C; Bialucha CU; Scuoppo C; Zender L; Krasnitz A; Xuan Z; Zuber J; Wigler M; Hicks J; McCombie RW; Hemann MT; Hannon GJ; Powers S; Lowe SW
Cancer Cell; 2009 Oct; 16(4):324-35. PubMed ID: 19800577
[TBL] [Abstract][Full Text] [Related]
2. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo.
Hemann MT; Fridman JS; Zilfou JT; Hernando E; Paddison PJ; Cordon-Cardo C; Hannon GJ; Lowe SW
Nat Genet; 2003 Mar; 33(3):396-400. PubMed ID: 12567186
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenesis by the p53 target PUMA.
Hemann MT; Zilfou JT; Zhao Z; Burgess DJ; Hannon GJ; Lowe SW
Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9333-8. PubMed ID: 15192153
[TBL] [Abstract][Full Text] [Related]
5. FoxOs in tumor suppression and stem cell maintenance.
Arden KC
Cell; 2007 Jan; 128(2):235-7. PubMed ID: 17254960
[TBL] [Abstract][Full Text] [Related]
6. Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors.
Horton SJ; Giotopoulos G; Yun H; Vohra S; Sheppard O; Bashford-Rogers R; Rashid M; Clipson A; Chan WI; Sasca D; Yiangou L; Osaki H; Basheer F; Gallipoli P; Burrows N; Erdem A; Sybirna A; Foerster S; Zhao W; Sustic T; Petrunkina Harrison A; Laurenti E; Okosun J; Hodson D; Wright P; Smith KG; Maxwell P; Fitzgibbon J; Du MQ; Adams DJ; Huntly BJP
Nat Cell Biol; 2017 Sep; 19(9):1093-1104. PubMed ID: 28825697
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.
Huang J; Zhang YL; Teng XM; Lin Y; Zheng DL; Yang PY; Han ZG
BMC Cancer; 2007 Jul; 7():126. PubMed ID: 17626620
[TBL] [Abstract][Full Text] [Related]
8. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis.
Sluss HK; Gannon H; Coles AH; Shen Q; Eischen CM; Jones SN
Mol Cancer Res; 2010 Feb; 8(2):216-22. PubMed ID: 20145032
[TBL] [Abstract][Full Text] [Related]
10. A CRISPR/Cas9 Functional Screen Identifies Rare Tumor Suppressors.
Katigbak A; Cencic R; Robert F; Sénécha P; Scuoppo C; Pelletier J
Sci Rep; 2016 Dec; 6():38968. PubMed ID: 27982060
[TBL] [Abstract][Full Text] [Related]
11. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
12. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
Drexler HG
Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
[TBL] [Abstract][Full Text] [Related]
13. Oncogene-induced senescence as an initial barrier in lymphoma development.
Braig M; Lee S; Loddenkemper C; Rudolph C; Peters AH; Schlegelberger B; Stein H; Dörken B; Jenuwein T; Schmitt CA
Nature; 2005 Aug; 436(7051):660-5. PubMed ID: 16079837
[TBL] [Abstract][Full Text] [Related]
14. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Opavsky R
EBioMedicine; 2021 Jan; 63():103191. PubMed ID: 33418509
[TBL] [Abstract][Full Text] [Related]
15. Dissecting p53 tumor suppressor functions in vivo.
Schmitt CA; Fridman JS; Yang M; Baranov E; Hoffman RM; Lowe SW
Cancer Cell; 2002 Apr; 1(3):289-98. PubMed ID: 12086865
[TBL] [Abstract][Full Text] [Related]
16. Irradiation selects for p53-deficient hematopoietic progenitors.
Marusyk A; Porter CC; Zaberezhnyy V; DeGregori J
PLoS Biol; 2010 Mar; 8(3):e1000324. PubMed ID: 20208998
[TBL] [Abstract][Full Text] [Related]
17. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
[TBL] [Abstract][Full Text] [Related]
18. Multiple tumor suppressor pathways negatively regulate telomerase.
Lin SY; Elledge SJ
Cell; 2003 Jun; 113(7):881-9. PubMed ID: 12837246
[TBL] [Abstract][Full Text] [Related]
19. Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression.
Beverly LJ; Felsher DW; Capobianco AJ
Cancer Res; 2005 Aug; 65(16):7159-68. PubMed ID: 16103066
[TBL] [Abstract][Full Text] [Related]
20. Cell death regulation during multistep lymphomagenesis.
Hsu B; Marin MC; McDonnell TJ
Cancer Lett; 1995 Jul; 94(1):17-23. PubMed ID: 7621440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
